Myositis-associated antibodies (MAA), excluding anti-SSA/SSB antibodies, were found in only two cases (5.9%) of SjS-ILD, while in the ASyS-ILD cohort, more than half of patients were positive (54.1%; p < 0.001). This evidence concerns the gene NAA10 and interstitial lung disease.